| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 50.90B | 52.06B | 50.54B | 47.97B | 47.94B | 48.54B |
| Gross Profit | 13.57B | 13.57B | 12.29B | 11.60B | 11.90B | 10.75B |
| EBITDA | 6.44B | 5.63B | 4.75B | 4.46B | 4.76B | 3.60B |
| Net Income | 3.38B | 3.10B | 2.47B | 2.09B | 2.48B | 1.67B |
Balance Sheet | ||||||
| Total Assets | 49.16B | 54.73B | 48.53B | 44.21B | 47.26B | 44.56B |
| Cash, Cash Equivalents and Short-Term Investments | 13.91B | 13.78B | 11.04B | 13.79B | 11.63B | 10.13B |
| Total Debt | 1.77B | 2.07B | 2.64B | 2.96B | 3.03B | 3.07B |
| Total Liabilities | 13.85B | 17.02B | 16.19B | 14.92B | 15.86B | 18.33B |
| Stockholders Equity | 34.86B | 37.37B | 31.94B | 28.62B | 30.77B | 25.38B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.58B | 67.00M | 2.38B | 2.50B | 608.00M |
| Operating Cash Flow | 0.00 | 5.71B | 594.00M | 2.63B | 2.90B | 1.11B |
| Investing Cash Flow | 0.00 | -1.33B | 1.25B | -591.00M | 532.00M | 1.34B |
| Financing Cash Flow | 0.00 | -2.85B | -2.07B | -1.71B | -2.93B | -1.70B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥39.91B | 15.17 | ― | 3.61% | -5.91% | -1.55% | |
77 Outperform | ¥36.10B | 10.80 | 10.08% | 4.65% | -3.66% | 31.12% | |
72 Outperform | ¥30.92B | 12.54 | ― | 3.21% | 12.64% | 30.73% | |
72 Outperform | ¥38.81B | 17.27 | ― | 2.59% | 21.47% | 30.64% | |
68 Neutral | ¥37.46B | 10.39 | ― | 3.38% | <0.01% | -17.60% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
56 Neutral | ¥34.42B | 27.54 | ― | 2.69% | -2.93% | -30.16% |